— Know what they know.
Not Investment Advice

SYBE OTC

SYBLEU Inc
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0%
$0.06
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 45 · $583742 mcap · 3M float · 0.098% daily turnover

Balance Sheet Trends

Total Assets
$61K +332.7% ▲
3Y CAGR: +92.5%
Total Liabilities
$327K +108.8% ▲
3Y CAGR: +206.8%
Shareholders Equity
-$266K -40.4% ▼
Cash & Investments
$37K -94.3% ▼
3Y CAGR: +94.0%
Total Debt
$140K +241.1% ▲
3Y CAGR: +131.2%
Net Debt
$103K +547.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022
— Assets —
Cash$5K$14K$67K$37K
Short-Term Investments$0$0$0$0
Cash & ST Investments$5K$14K$67K$37K
Net Receivables$0$0$0$0
Inventory$0$0$0$0
Other Current Assets$0$0$0$0
Total Current Assets$9K$14K$67K$53K
Property, Plant & Equip.$0$0$0$0
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$0$185K$10K$2K
Other Non-Current Assets$0$0$0$6K
Total Non-Current Assets$0$185K$10K$8K
Total Assets$9K$200K$76K$61K
— Liabilities —
Accounts Payable$0$0$0$0
Short-Term Debt$11K$9K$140K$140K
Deferred Revenue$0$0$0$0
Other Current Liabilities$0$0$0$0
Total Current Liabilities$11K$31K$165K$171K
Long-Term Debt$0$0$0$0
Other Non-Current Liab.$0$0$0$0
Total Non-Current Liabilities$0$173K$162K$156K
Total Liabilities$11K$204K$326K$327K
— Equity —
Common Stock$935$1K$1K$1K
Retained Earnings-$4K-$106K-$351K-$389K
Accumulated OCI$0$0$0$0
Total Stockholders Equity-$3K-$5K-$250K-$266K
Total Liabilities & Equity$9K$200K$76K$61K
— Key Metrics —
Total Debt$11K$9K$140K$140K
Net Debt$6K-$5K$73K$103K
Total Investments$0$185K$10K$2K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms